Joseph Sardano, Founder and CEO, Sensus Healthcare presents compelling data on the effectiveness of a non-surgical alternative to Mohs surgery for treating skin cancer and keloids.\xa0 Using Superficial Radiation Therapy otherwise known as photon radiotherapy, the Sensus SRT system allows for non-invasive treatments without leaving a scar.\xa0 In the age of COVID-19, dermatologists are finding this an excellent alternative to surgery particularly to treat those over 65 with pre-existing conditions.
@Sensushealth\xa0 #skincancer\xa0 #Keloid\xa0 #Mohs #SRT #COVID19